Epigenetic and transcriptomic mechanisms (Table 3 (a–c)) play critical roles in the development and progression of BRAF-mutant melanoma, significantly contributing to tumor heterogeneity, therapeutic resistance, and immune evasion. This evidence concerns the gene BRAF and neoplasm.